Utility of GATA3, Uroplakin-II, and p40 Markers in the Diagnosis of Urothelial Carcinoma

Lavanya Manjari, Amrutha M R, Ramesh K R, Vivek P O, Shruthi H

Open source

DOI
10.7759/cureus.113714
Published
2026-07-31
Container
Cureus
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.113714,
  title = {Utility of GATA3, Uroplakin-II, and p40 Markers in the Diagnosis of Urothelial Carcinoma},
  author = {Lavanya Manjari and Amrutha M R and Ramesh K R and Vivek P O and Shruthi H},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.113714},
  url = {https://doi.org/10.7759/cureus.113714}
}

RIS

TY  - JOUR
TI  - Utility of GATA3, Uroplakin-II, and p40 Markers in the Diagnosis of Urothelial Carcinoma
AU  - Lavanya Manjari
AU  - Amrutha M R
AU  - Ramesh K R
AU  - Vivek P O
AU  - Shruthi H
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.113714
UR  - https://doi.org/10.7759/cureus.113714
ER  - 

APA

Manjari, L., R, A. M., R, R. K., O, V. P., & H, S. (2026). Utility of GATA3, Uroplakin-II, and p40 Markers in the Diagnosis of Urothelial Carcinoma. Cureus. https://doi.org/10.7759/cureus.113714

Source records